Significant potentiation of the behavioral effects of DOPA were observed in mice pretreated with GH-RIH. In addition, a slight reduction of oxotremorine induced symptoms was seen. No significant effects of GH-RIH were observed in several other tests involving the central nervous system (CNS). The results support our concept of the CNS actions of peptides.
- Central nervous system
- Growth hormone
- Growth-hormone release inhibiting hormone
ASJC Scopus subject areas
- Behavioral Neuroscience